Xian-Janssen And China International Medical Foundation To Start Migraine Care Program
This article was originally published in PharmAsia News
Xian-Janssen and China International Medical Foundation have signed an agreement on "GoldenLink," a joint migraine care program. Headed by an expert panel, it will furnish a broad platform for migraine physicians to provide more proper treatment. With the support of Chinese Medical Association and CIMF, GoldenLink will promote standardization of migraine diagnosis and treatment procedures, improve epidemiology data, train more physicians, as well as establish migraine centers and clinics to service more patients. Xian-Janssen will fund the program fully in 2009. (Click here for more - Chinese Language)
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.